Cometriq (cabozantinib)
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
May 2016
WARNINGS AND PRECAUTIONS
Embryo-Fetal Toxicity
Based on data from animal studies and its mechanism of action, COMETRIQ...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts